Treatment of focal segmental glomerulosclerosis with immunophilin modulation: when did we stop thinking about pathogenesis?
about
MYO1E mutations and childhood familial focal segmental glomerulosclerosis.Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study designEffect of cyclosporin A on proteinuria in the course of glomerulopathy associated with WT1 mutations.Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosisSerum microRNAs levels in primary focal segmental glomerulosclerosis.Adrenocorticotropic hormone analog use for podocytopathiesUrinary IgG and α2-macroglobulin are powerful predictors of outcome and responsiveness to steroids and cyclophosphamide in idiopathic focal segmental glomerulosclerosis with nephrotic syndromeFocal segmental glomerulosclerosis after renal transplantation.Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients.Rituximab in immunologic glomerular diseases.Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future.Role of protein kinase A signaling pathway in cyclosporine nephrotoxicity.Protective effect of schisandrin B against cyclosporine A-induced nephrotoxicity in vitro and in vivo.Cyclosporine A and steroid therapy in childhood steroid-resistant nephrotic syndrome.Is the antiproteinuric effect of cyclosporine a independent of its immunosuppressive function in T cells?Second-line options for refractory steroid-sensitive and -resistant nephrotic syndrome.Nuclear factor of activated T cells mediates RhoA-induced fibronectin upregulation in glomerular podocytes.Efficacy and Safety of Cyclosporine versus Tacrolimus in Steroid and Cyclophosphamide Resistant Nephrotic Syndrome: A Prospective Study.Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases.Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature.Intravascular lymphoma forming massive aortic tumors complicated with sarcoidosis and focal segmental glomerulosclerosis: a case report and literature review
P2860
Q30541167-EE3BCCBB-C64B-4607-8CDA-0269DCFB02F1Q33817568-8A303D9A-717B-4FD5-91ED-B5B478C504BDQ34746123-B347B012-5B43-4892-A782-8768CE1733CDQ36203830-3207FB54-6734-4D6C-AD0F-CB92D18B2B4FQ37043319-F5537359-5F98-4479-A89C-F7D62F6C3EE8Q37070458-6BBC2EBC-489B-4351-B524-1370D4A2137BQ37182778-BE82BAC4-FBDA-4195-870B-EF5F16A7AD9FQ37882019-AD2DF56A-275D-4065-A3B7-A383710C1E7AQ37928188-D8D86D8F-859B-487C-BAEA-716B155B066FQ37989298-C2FCC2C4-D401-406D-BA82-7D3468360513Q38270521-F984ED93-B349-4EB1-A2A5-234628C72E56Q38999902-F90C0B9B-B1BB-4435-90B8-F816F1113894Q39323113-B5605CDB-0F40-453B-A0D2-231575CF7160Q41822387-E549B61F-1D65-4BD1-BEF9-FA6EDA56AB64Q42217411-80CDC30C-0609-4AF0-8580-DAEA8885CF44Q42723614-BE600508-DF1F-4E8E-B557-9F077CB97323Q46736252-711986B4-A101-4634-A238-7D415C8326ADQ50417540-37B12F21-D561-48B0-A35B-0DDD8446A30BQ51034723-68DB3815-C4BE-4F8B-B0AB-7127404A1B25Q53675239-16739B2A-6223-4A3E-A8AE-8963DD2A2CCDQ58101276-FDE4BC0E-AD6E-4C25-9E6E-C41231CBB58C
P2860
Treatment of focal segmental glomerulosclerosis with immunophilin modulation: when did we stop thinking about pathogenesis?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of focal segmental g ...... p thinking about pathogenesis?
@en
Treatment of focal segmental g ...... p thinking about pathogenesis?
@nl
type
label
Treatment of focal segmental g ...... p thinking about pathogenesis?
@en
Treatment of focal segmental g ...... p thinking about pathogenesis?
@nl
prefLabel
Treatment of focal segmental g ...... p thinking about pathogenesis?
@en
Treatment of focal segmental g ...... p thinking about pathogenesis?
@nl
P356
P1433
P1476
Treatment of focal segmental g ...... p thinking about pathogenesis?
@en
P2093
Alain Y Meyrier
P2888
P304
P356
10.1038/KI.2009.204
P407
P577
2009-06-03T00:00:00Z